. In 10 congenital hypothyroid subjects aged 7 to 18 yrs (6 prepubertal girls and 4 pubertal boys). L-14 treatment uas discontinued for a 3reek period in order to perform thyroid scan. All of Lhem underwent iv LH-RH-test immediately before and 20 days after the therapy withdrawal All the blood samples were processed in the same run. The shifting of TSII. 74 and 13 serum values from the euthyroid to the hypothyroid range uas accompanied in all the patients by a significant increase in both baseline LH (12.9+4.7 vs 6.3+2.5 mIU/ml, 2 p 4. 0.001) and PRL (22.6+11.7 vs 11.6+3.0 ng1.l. 2 p<0.05) plasma levels On the contrary LH peak after LHRH (22.5+7.9 vs 20.1+10.4) and either basal (2.4+ +1.5 vs 3.2+ 2.1 mIUIm1) or stimulated (7.9+2.0 vs 6.8+2.0) FSH concentrations we---
re not affected by L-14 withdrawal. These results indicate that: a) an evident increase in LH serum levels precociously occurs in response to thyroid failure; b) such increase does not reflect an enhanced sensitivity to LHRH; c) it may reflect anomalous LH reactivity to IRH (Oe Luca et al, Ped Res 18, 1222 , 1984 We have performed a TRH test in 25 children of both sexes, aged 5-13 112 years, clinically euthyroid, on unchanged monotherapy from the start (at least 2 years).Serum basal levels of TSH, T4'
T , TBG and serum TSH levels after TRH were assayed by commercial R?A kits.Statistica1 analyses included mean,SD, Student's t test.
Valproate-treated children (VPA-C) (10 subjects) showed TSH levels both before (pt0.05) and after TRH (pc0.01 or 0.001) higher than normal children (NC). Serum T levels in VPA-C, carbamaze-4 . pi,ie-treated children (CBZ-C) (7 subjects) (p10.001) and phenobarbital-treated children (PB-C) (8 subjects) were lower than in NC (~40.01). PB-C had higher T4 le,vels than CBZ-C (pdO.01).
Our data show a subclinical primary hypothyroidism in VPA-C. Low T with normal TBG and normal levels of TSH both before and 4 after TRH in CBZ-C and PB-C could be explained by a decreased thyroidal synthesis and/or an enhanced peripheral metabolism with a concomitant depressive influence on hypothalamic-pituitary axis or a T -depending cellular euthyroidism. We report 3 112 year old twin boys with prolonged neonatal thyrotoxicosis and persistently low TSH secretion manifested by a diminished TSH response to hypothyroxinemia and to TRH stimulation. Features of neonatal thyrotoxicosis included: intrauterine growth retardation, microcephaly wit11 ventriculomegaly, poor weight gain, hyperphagia, irritability, diarrhea, exophthalmos, tachycardia, hepatosplenomegaly, and direct hyperbilirubinemia. However, there was no goiter or history of maternal tliyroid disease and diagnosis was delayed until 11 weeks of age (T4>29 ugldl, T3>580 ngldl).
By age 6 mo., on propylthiouricil (PTU) 25 mg b.i.d., both infants had TSH levels <2 uUlml (normal N=O.4-4.5) despite T4 levels <1 and 3.1 ug/dl (N=7.2-15.6) and free T4 (FT4) levels of 0.3 and 0.5 ng/dl (N=0.8-1.9).
At 3 4/12 years, while on PTU 50 mg q.i.d., they again became hypothyroid with FT4s of <0.2 and T3RIA of 47 and 43 ng/dl (N=80-220) with a TSH of 3. [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] . The material was characterized with r e s p c t to sex, age, tissue type (HA-B8/DR3), thyroid h o n m n e values, autoantibodies (TSH-receptor a n t M i e s , TRAK; microsamal and thyrqlobulin antibodies) and thyroid fine-needle biopsy at diagnosis. M e n period o f anti-thyroid therapy 33 m n t h s , wan follow-up period 67 mnths. 22 pat. (61%) have either relapsed following withdrawal o f antithyroid treatmnt (17/36) o r have had to undergo surgery because o f large goiter and/or poor response t o medication (5/36). The remaining 14 pat. (39%) are still in remission. In the relapse v s remission group the presence o f TRAK was 74% v s 18% and a lymphocytic thyroiditis at biopsy 33% v s 64%. None o f the other factors examined a t diagnosis differed. At follow-up the material was re-evaluated with biopsy and autoantibodies. Evidence of Hash* to's thyroiditis (H) was found in six patients all in remission. The other pat. were classified as Grave's disease (G) and only 8 (27%) were in remission. It is obvious that there is a need for better diagnostic and prognostic tools to avoid long term treat--m t i n H. and consider alternative therapy in G. Goiter grading according to WHO standards is a rather crude method used for population studies mainly. In the individual child where usually smaller goiters of grade Ia and Ib are diagnosed it might be difficult to define absence or presence of goiter by palpation and inspection alone. The purpose of this i nvestigation was to obtain normal thyroid volumes by means of u ltrasonography in healthy children of various ages and to compare these volumes with a group of goitrous children. A total of 621 children (322 girls, 294 boys) of 6 to 16 years of age was investigated. 278 (157 girls, 121 boys) had a goiter on physical examination. Ultrasonography was performed at school using a portable realtime scanner with 4 MHz linear transducer. Volume was estimated on the basis of ellipsoid thyroid configuration. In healthy boys total thyroid volume increased from 1.8 k 0.6 (M+SD) to 8.4 _t 3.4 rnl from 6 to 16 years respectively, in girls the volume changed from 2.3 f 1.3 to 10.5 t 5.1 ml from 6 to 15 years respectively. Goitrous children had larger volumes. There was however a strong tendency for overdiagnosis on clinical basis. A short obese neck prevents the goiter from clinical detection whereas a rather long and lean neck may lead to clinical overdiagnosis. In summary normal thyroid volumes o f children were provided by means of sonography which represents the best suitable method to assess volume changes following treatment procedures.
